Fir Tree Capital Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2017
Q1 | – | Sell |
-3,177,812
| Closed | -$115M | – | 68 |
|
2016
Q4 | $115M | Buy |
3,177,812
+351,600
| +12% | +$12.7M | 4.65% | 9 |
|
2016
Q3 | $130M | Buy |
2,826,212
+70,439
| +3% | +$3.24M | 5.56% | 7 |
|
2016
Q2 | $138M | Sell |
2,755,773
-936,156
| -25% | -$47M | 5.67% | 8 |
|
2016
Q1 | $198M | Sell |
3,691,929
-576,365
| -14% | -$30.8M | 7.48% | 4 |
|
2015
Q4 | $280M | Sell |
4,268,294
-425,549
| -9% | -$27.9M | 4.97% | 6 |
|
2015
Q3 | $265M | Buy |
4,693,843
+3,272,636
| +230% | +$185M | 4.44% | 7 |
|
2015
Q2 | $84M | Buy |
1,421,207
+1,171,207
| +468% | +$69.2M | 1.34% | 28 |
|
2015
Q1 | $15.6M | Sell |
250,000
-2,971,114
| -92% | -$185M | 0.22% | 43 |
|
2014
Q4 | $185M | Sell |
3,221,114
-615,909
| -16% | -$35.4M | 1.93% | 22 |
|
2014
Q3 | $206M | Buy |
3,837,023
+1,191,300
| +45% | +$64M | 2.31% | 17 |
|
2014
Q2 | $139M | Sell |
2,645,723
-4,413
| -0.2% | -$231K | 1.5% | 24 |
|
2014
Q1 | $140M | Sell |
2,650,136
-500,000
| -16% | -$26.4M | 1.57% | 24 |
|
2013
Q4 | $126M | Buy |
+3,150,136
| New | +$126M | 1.44% | 24 |
|